Peter N. Reikes

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
Carlsbad, CA
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
By: Patrick R. O'Neil, attorney-in-fact For: Peter N. Reikes
Source: Latest parsed Forms 3/4/5 signature
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Peter N. Reikes

Form 4 holding Director

IONIS PHARMACEUTICALS INC

Security class
Common Stock
Shares / value
14,222
Estimated value
$717,031
Report date
15 Oct 2021
Price
$50.42
Ownership
Direct
Form 4 holding Director

IONIS PHARMACEUTICALS INC

Security class
Restricted Stock Unit
Shares / value
10,664
Estimated value
$537,647
Report date
15 Oct 2021
Price
$50.42
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

IONIS PHARMACEUTICALS INC

Security class
Non-Qualified Stock Option (right to buy)
Shares / value
10,753
Estimated value
Report date
04 Jun 2026
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Peter N. Reikes

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .